Target intelligence / Profile preview

Catenin delta-2 (CTNND2) (CTNND2)

Target
CTNND2
Molecular classification
Armadillo repeat protein, Cell adhesion molecule, Catenin family
01

Overview

Catenin delta-2 (CTNND2), commonly referred to as δ-catenin, is a member of the p120-catenin subfamily of armadillo repeat proteins that plays a vital role in regulating cell-cell adhesion and cytoskeletal organization (UniProt P98170). Under normal physiological conditions, its expression is primarily restricted to the central nervous system, where it is essential for neuronal development, dendritic branching, and synaptic plasticity. However, δ-catenin is frequently overexpressed in several epithelial malignancies, including prostate, breast, and lung cancers, where it functions as a tumor-associated antigen (TAA) (Lu et al., 2005, Journal of Urology). Its overexpression is linked to increased tumor cell proliferation, migration, and invasion, often mediated through the modulation of Wnt/β-catenin signaling and Rho GTPase activity (Zeng et al., 2020, Frontiers in Oncology). Because of its high tumor-to-normal tissue expression ratio outside the CNS, δ-catenin is being investigated as a target for immunotherapies, such as peptide-based vaccines and CAR-T cell therapies, designed to elicit a specific immune response against malignant cells (No et al., 2011, Journal of Immunotherapy).

Other names
Delta-cateninNeural cateninNPRAPGT24δ-catenin
02

Mechanism of action

Induction of cytotoxic T-lymphocyte (CTL) response against tumor cells overexpressing the antigen or direct inhibition of protein function to reduce tumor invasiveness.

03

Biological functions

Cell-cell adhesionSignal transductionDendritic morphogenesisWnt signaling regulationCell motility
04

Disease associations

Prostate cancerBreast cancerLung cancerOvarian cancerCri-du-chat syndrome
05

Safety considerations

Potential neurotoxicity due to endogenous expression in the central nervous systemRisk of autoimmune response
06

Interacting drugs

Experimental peptide vaccines

1 more in the full profile.

07

Biomarkers

CTNND2 protein expressionCTNND2 mRNA levels

Beyond the preview

Go deeper on Catenin delta-2 (CTNND2) (CTNND2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Catenin delta-2 (CTNND2) (CTNND2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call